Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Glutamate-glutamine homeostasis is perturbed in neurons and astrocytes derived from patient iPSC models of frontotemporal dementia

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hippocampal volume and cell number in depression, schizophrenia, and suicide subjects

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Transcriptomic profiling of trigeminal nucleus caudalis and spinal cord dorsal horn

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. DNMT1 regulates expression of MHC class i in post-mitotic neurons

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Author Correction: Identification of epilepsy-associated neuronal subtypes and gene expression underlying epileptogenesis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Identification of epilepsy-associated neuronal subtypes and gene expression underlying epileptogenesis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. DNA methylation regulates CHRNA7 transcription and can be modulated by valproate

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Henrik H Hansen
  • Katrine Fabricius
  • Pernille Barkholt
  • Jens D Mikkelsen
  • Jacob Jelsing
  • Charles Pyke
  • Lotte Bjerre Knudsen
  • Niels Vrang
View graph of relations

Exendin-4, a glucagon-like peptide-1 (GLP-1) receptor agonist, have been demonstrated to promote neuroprotection in the rat 6-hydroxydopamine (6-OHDA) neurotoxin model of Parkinson's disease (PD), a neurodegenerative disorder characterized by progressive nigrostriatal dopaminergic neuron loss. In this report, we characterized the effect of a long-acting GLP-1 receptor agonist, liraglutide (500µg/kg/day, s.c.) in the context of a partial or advanced (full) 6-OHDA induced nigral lesion in the rat. Rats received a low (3µg, partial lesion) or high (13.5µg, full lesion) 6-OHDA dose stereotaxically injected into the right medial forebrain bundle (n=17-20 rats per experimental group). Six weeks after induction of a partial nigral dopaminergic lesion, vehicle or liraglutide was administered for four weeks. In the full lesion model, vehicle dosing or liraglutide treatment was applied for a total of six weeks starting three weeks pre-lesion, or administered for three weeks starting on the lesion day. Quantitative stereology was applied to assess the total number of midbrain tyrosine hydroxylase (TH) positive dopaminergic neurons. As compared to vehicle controls, liraglutide had no effect on the rotational responsiveness to d-amphetamine or apomorphine, respectively. In correspondence, while numbers of TH-positive nigral neurons were significantly reduced in the lesion side (partial lesion ≈55%; full lesion ≈90%) liraglutide administration had no influence dopaminergic neuronal loss in either PD model setting. In conclusion, liraglutide showed no neuroprotective effects in the context of moderate or substantial midbrain dopaminergic neuronal loss and associated functional motor deficits in the rat 6-OHDA lesion model of PD.

Original languageEnglish
JournalBrain Research
Volume1646
Pages (from-to)354-65
Number of pages12
ISSN0006-8993
DOIs
Publication statusPublished - 1 Sep 2016

    Research areas

  • Journal Article

ID: 49674210